Efecto de la suplementación oral con una fórmula que contiene ácido R-lipoico en pacientes con glaucoma
Authors:
- V. Zanón-MorenoVZV. Zanón-Moreno
- A.I. RamírezA.I. Ramírez
- Pinazo- DuránPDPinazo- Durán
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 95 (3) , 120-129
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Predicting Vision-Related Disability in GlaucomaOphthalmology, 2018
- Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma—study protocolBritish Journal of Ophthalmology, 2017
- Phenotypic Description of the Spanish Multicentre Genetic Glaucoma Group CohortJournal of Ophthalmology, 2017
- α-lipoic acid protects against hypoxia/reoxygenation-induced injury in human umbilical vein endothelial cells through suppression of apoptosis and autophagyMolecular Medicine Reports, 2015
- A two‐year follow‐up of oral antioxidant supplementation in primary open‐angle glaucoma: an open‐label, randomized, controlled trialActa Ophthalmologica, 2014
- New perspectives on target intraocular pressureSurvey of Ophthalmology, 2014
- α-Lipoic Acid Antioxidant Treatment Limits Glaucoma-Related Retinal Ganglion Cell Death and DysfunctionPLOS ONE, 2013
- Oxidative Stress in Primary Open-angle GlaucomaJournal of Glaucoma, 2008
- Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acidsProstaglandins, Leukotrienes and Essential Fatty Acids, 2006
- Nutritional and clinical relevance of lutein in human healthBritish Journal of Nutrition, 2003